Hajam Irshad Ahmed, Lee John Hwa
College of Veterinary Medicine, Chonbuk National University, Iksan Campus, 570-752, Republic of Korea.
College of Veterinary Medicine, Chonbuk National University, Iksan Campus, 570-752, Republic of Korea.
Vet Microbiol. 2017 Jun;205:117-123. doi: 10.1016/j.vetmic.2017.05.021. Epub 2017 May 29.
Recombinant Salmonella strains expressing foreign heterologous antigens have been extensively studied as promising live vaccine delivery vehicles. In this study, we constructed attenuated smooth (S-HA) and rough (R-HA) Salmonella strains expressing hemagglutinin (HA) of H9N2, a low pathogenic avian influenza A virus. We then investigated the HA-specific immune responses following oral immunization with either S-HA or R-HA strain in chicken model. We further examined the effects of the preexisting anti-Salmonella immunity on the subsequent elicitation of the HA and the Salmonella ompA specific immune responses. Our results showed that primary immunization with either the S-HA or the R-HA strain elicited comparable HA-specific immune responses and the responses were significantly (p<0.05) higher compared to the Salmonella vector control. When chickens were pre-immunized with the smooth Salmonella carrier alone and then vaccinated with either S-HA or R-HA strain 3, 6 and 9 weeks later, respectively, significant reductions were seen for HA-specific immune responses at week 6, a point which corresponded to the peak of the primary Salmonella-specific antibody responses. No reductions were seen at week 3 and 9, albeit, the HA-specific immune responses were boosted at week 9, a point which corresponded to the lowest primary Salmonella-specific antibody responses. The ompA recall responses remain refractory at week 3 and 6 following deliberate immunization with the carrier strain, but were significantly (p<0.05) increased at week 9 post-primary immunization. We conclude that preexisting anti-Salmonella immunity inhibits antigen-specific immune responses and this effect could be avoided by carefully selecting the time point when carrier-specific immune responses are relatively low.
表达外源异源抗原的重组沙门氏菌菌株作为有前景的活疫苗递送载体已得到广泛研究。在本研究中,我们构建了表达低致病性甲型禽流感病毒H9N2血凝素(HA)的减毒光滑型(S-HA)和粗糙型(R-HA)沙门氏菌菌株。然后,我们在鸡模型中研究了用S-HA或R-HA菌株口服免疫后的HA特异性免疫反应。我们进一步研究了预先存在的抗沙门氏菌免疫力对随后引发的HA和沙门氏菌ompA特异性免疫反应的影响。我们的结果表明,用S-HA或R-HA菌株进行初次免疫引发了相当的HA特异性免疫反应,并且与沙门氏菌载体对照相比,这些反应显著更高(p<0.05)。当鸡仅用光滑型沙门氏菌载体进行预免疫,然后分别在3、6和9周后用S-HA或R-HA菌株进行疫苗接种时,在第6周观察到HA特异性免疫反应显著降低,这一点与初次沙门氏菌特异性抗体反应的峰值相对应。在第3周和第9周未观察到降低,尽管如此,在第9周HA特异性免疫反应得到增强,这一点与最低的初次沙门氏菌特异性抗体反应相对应。在用载体菌株进行故意免疫后第3周和第6周,ompA回忆反应仍然难以激发,但在初次免疫后第9周显著增加(p<0.05)。我们得出结论,预先存在的抗沙门氏菌免疫力会抑制抗原特异性免疫反应,通过仔细选择载体特异性免疫反应相对较低的时间点可以避免这种影响。